Peapack Gladstone Financial Corp cut its stake in CVS Health Corporation (NYSE:CVS) by 1.5% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 205,246 shares of the pharmacy operator’s stock after selling 3,021 shares during the period. Peapack Gladstone Financial Corp’s holdings in CVS Health Corporation were worth $16,112,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the company. Macquarie Group Ltd. boosted its position in shares of CVS Health Corporation by 16.6% in the fourth quarter. Macquarie Group Ltd. now owns 9,526,280 shares of the pharmacy operator’s stock valued at $751,719,000 after buying an additional 1,359,100 shares in the last quarter. Pioneer Investment Management Inc. boosted its position in shares of CVS Health Corporation by 4.6% in the first quarter. Pioneer Investment Management Inc. now owns 8,033,087 shares of the pharmacy operator’s stock valued at $630,598,000 after buying an additional 353,621 shares during the last quarter. Parnassus Investments CA boosted its position in shares of CVS Health Corporation by 2.9% in the first quarter. Parnassus Investments CA now owns 6,237,016 shares of the pharmacy operator’s stock valued at $473,605,000 after buying an additional 175,695 shares during the last quarter. Bank of Montreal Can boosted its position in shares of CVS Health Corporation by 10.7% in the first quarter. Bank of Montreal Can now owns 4,939,142 shares of the pharmacy operator’s stock valued at $387,722,000 after buying an additional 475,722 shares during the last quarter. Finally, LSV Asset Management boosted its position in shares of CVS Health Corporation by 44.2% in the first quarter. LSV Asset Management now owns 4,579,916 shares of the pharmacy operator’s stock valued at $359,523,000 after buying an additional 1,404,384 shares during the last quarter. 81.92% of the stock is currently owned by institutional investors.

Shares of CVS Health Corporation (CVS) opened at 77.97 on Monday. The firm has a 50-day moving average of $78.75 and a 200-day moving average of $79.09. The firm has a market capitalization of $79.44 billion, a PE ratio of 16.26 and a beta of 0.91. CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $98.44.

The company also recently declared a quarterly dividend, which was paid on Thursday, August 3rd. Shareholders of record on Monday, July 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.57%. The ex-dividend date of this dividend was Thursday, July 20th. CVS Health Corporation’s dividend payout ratio (DPR) is currently 41.67%.

COPYRIGHT VIOLATION NOTICE: “Peapack Gladstone Financial Corp Sells 3,021 Shares of CVS Health Corporation (NYSE:CVS)” was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/07/peapack-gladstone-financial-corp-sells-3021-shares-of-cvs-health-corporation-nysecvs.html.

Several brokerages have commented on CVS. BidaskClub upgraded shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, August 2nd. Jefferies Group LLC reiterated a “hold” rating and issued a $82.00 target price on shares of CVS Health Corporation in a report on Friday, July 14th. Guggenheim reiterated a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 3rd. Needham & Company LLC began coverage on shares of CVS Health Corporation in a report on Tuesday, June 27th. They issued a “hold” rating for the company. Finally, Leerink Swann set a $90.00 target price on shares of CVS Health Corporation and gave the stock a “buy” rating in a report on Tuesday, June 27th. Nine research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $92.20.

In other CVS Health Corporation news, CFO David M. Denton sold 230,510 shares of the company’s stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the completion of the transaction, the chief financial officer now owns 176,983 shares of the company’s stock, valued at approximately $14,158,640. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Helena Foulkes sold 20,333 shares of the company’s stock in a transaction that occurred on Monday, June 26th. The stock was sold at an average price of $80.00, for a total value of $1,626,640.00. Following the transaction, the executive vice president now directly owns 59,301 shares of the company’s stock, valued at approximately $4,744,080. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 271,175 shares of company stock valued at $21,632,597. Insiders own 0.61% of the company’s stock.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.